Pipeline Previews

January 2015 | Volume 14 | Issue 1 | Features | 92 | Copyright © January 2015


Pipeline Previews brings to you information on the newest drugs and medical products as they become available to the dermatologic community. This department may include additional information from the manufacturers, plus reports from physicians who wish to share their clinical experience with these new products. In addition, we will inform our readers about the latest drugs receiving Food and Drug Administration (FDA) approval.

Valeant Pharmaceuticals Announces FDA Approval of Onexton

Apremilast Approval Expanded to Include Plaque Psoriasis

iCAD/Xoft System- New Axxent SPX Controller

Promius Pharma Launches Promiseb

Novartis Announces FDA Advisory Committee Unanimously Recommends Approval of AIN457 (secukinumab) for Patients With Moderate to Severe Plaque Psoriasis